These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21455633

  • 1. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
    Naghibalhossaini F, Hosseini HM, Mokarram P, Zamani M.
    Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633
    [Abstract] [Full Text] [Related]

  • 2. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.
    Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL, Ashktorab H.
    Clin Cancer Res; 2009 Feb 15; 15(4):1155-61. PubMed ID: 19190129
    [Abstract] [Full Text] [Related]

  • 3. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I.
    Int J Cancer; 2014 May 15; 134(10):2342-51. PubMed ID: 24166180
    [Abstract] [Full Text] [Related]

  • 4. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M.
    Ann Oncol; 2009 Jul 15; 20(7):1216-22. PubMed ID: 19164452
    [Abstract] [Full Text] [Related]

  • 5. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
    Nagasaka T, Koi M, Kloor M, Gebert J, Vilkin A, Nishida N, Shin SK, Sasamoto H, Tanaka N, Matsubara N, Boland CR, Goel A.
    Gastroenterology; 2008 Jun 15; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, Kang GH.
    Pathol Int; 2008 Feb 15; 58(2):104-13. PubMed ID: 18199160
    [Abstract] [Full Text] [Related]

  • 7. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B, Sari M, Karadayi K, Turan M, Ozdemir O, Bagci G.
    Cancer Biomark; 2016 Jun 24; 17(2):133-43. PubMed ID: 27540971
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.
    Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217
    [Abstract] [Full Text] [Related]

  • 9. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep 01; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 10. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR.
    Gastroenterology; 2015 Jan 01; 148(1):88-99. PubMed ID: 25305506
    [Abstract] [Full Text] [Related]

  • 11. Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.
    Imamura Y, Morikawa T, Liao X, Lochhead P, Kuchiba A, Yamauchi M, Qian ZR, Nishihara R, Meyerhardt JA, Haigis KM, Fuchs CS, Ogino S.
    Clin Cancer Res; 2012 Sep 01; 18(17):4753-63. PubMed ID: 22753589
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
    Hinoue T, Weisenberger DJ, Pan F, Campan M, Kim M, Young J, Whitehall VL, Leggett BA, Laird PW.
    PLoS One; 2009 Dec 21; 4(12):e8357. PubMed ID: 20027224
    [Abstract] [Full Text] [Related]

  • 13. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
    Imamura Y, Lochhead P, Yamauchi M, Kuchiba A, Qian ZR, Liao X, Nishihara R, Jung S, Wu K, Nosho K, Wang YE, Peng S, Bass AJ, Haigis KM, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S.
    Mol Cancer; 2014 May 31; 13():135. PubMed ID: 24885062
    [Abstract] [Full Text] [Related]

  • 14. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
    Ta TV, Nguyen QN, Chu HH, Truong VL, Vuong LD.
    Pathol Res Pract; 2020 Apr 31; 216(4):152898. PubMed ID: 32089414
    [Abstract] [Full Text] [Related]

  • 15. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
    Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ.
    Am J Surg Pathol; 2004 Nov 31; 28(11):1452-9. PubMed ID: 15489648
    [Abstract] [Full Text] [Related]

  • 16. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.
    BMC Cancer; 2008 Sep 09; 8():255. PubMed ID: 18782444
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
    Kakar S, Deng G, Smyrk TC, Cun L, Sahai V, Kim YS.
    Mod Pathol; 2012 Jul 09; 25(7):1040-7. PubMed ID: 22522845
    [Abstract] [Full Text] [Related]

  • 18. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer.
    Tanaka N, Huttenhower C, Nosho K, Baba Y, Shima K, Quackenbush J, Haigis KM, Giovannucci E, Fuchs CS, Ogino S.
    Am J Pathol; 2010 Dec 09; 177(6):2731-40. PubMed ID: 21037082
    [Abstract] [Full Text] [Related]

  • 19. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.
    Hum Pathol; 2007 Apr 09; 38(4):614-20. PubMed ID: 17270239
    [Abstract] [Full Text] [Related]

  • 20. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F, Surve P, Natarajan S, Patil A, Pol S, Patole K, Das BR.
    Cancer Genet; 2020 Feb 09; 241():42-50. PubMed ID: 31653608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.